Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19601 | 433 | 35.0 | 51% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2307 | 4094 | HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GRP PEPTIDE CHEM | Address | 6 | 15% | 9% | 38 |
2 | BRANCHED POLYPEPTIDES | Author keyword | 6 | 100% | 1% | 4 |
3 | HUNGARIAN SCI PEPTIDE CHEM GRP | Address | 4 | 67% | 1% | 4 |
4 | BRANCHED CHAIN POLYPEPTIDE | Author keyword | 3 | 100% | 1% | 3 |
5 | METHOTREXATE ALBUMIN | Author keyword | 3 | 100% | 1% | 3 |
6 | EXPT ANTICANC THER Y | Address | 2 | 50% | 1% | 3 |
7 | MACROMOLECULAR CARRIERS | Author keyword | 2 | 50% | 1% | 3 |
8 | RESIDUALIZING LABELS | Author keyword | 2 | 43% | 1% | 3 |
9 | 256 CARCINOSARCOMA WALKER | Author keyword | 1 | 100% | 0% | 2 |
10 | ANTIFOLATE AGENT | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARRIER DESIGN | 17 | 75% | 3% | 12 |
2 | POLYL LYSINE BACKBONE | 17 | 75% | 3% | 12 |
3 | METHOTREXATE ALBUMIN | 5 | 45% | 2% | 9 |
4 | BRANCHED POLYPEPTIDES | 5 | 43% | 2% | 9 |
5 | CHAIN POLYPEPTIDES | 2 | 67% | 0% | 2 |
6 | DRUG CARRIER CONJUGATE | 2 | 67% | 0% | 2 |
7 | MTX HSA | 2 | 33% | 1% | 5 |
8 | ENHANCED TUMOR UPTAKE | 1 | 38% | 1% | 3 |
9 | CARRIER BOUND METHOTREXATE | 1 | 100% | 0% | 2 |
10 | MONOCLONAL ANTI MM46 ANTIBODY | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Albumin binding ligands and albumin conjugate uptake by cancer cells | 2011 | 10 | 15 | 53% |
Native albumin for targeted drug delivery | 2010 | 30 | 44 | 36% |
A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis | 2013 | 19 | 102 | 17% |
The Linkage of Cytotoxic Drugs to Monoclonal Antibodies for the Treatment of Cancer | 1990 | 44 | 46 | 48% |
DESIGN OF SYNTHETIC BRANCHED-CHAIN POLYPEPTIDES AS CARRIERS FOR BIOACTIVE MOLECULES | 1995 | 18 | 55 | 62% |
MACROMOLECULAR DRUG CARRIER SYSTEMS IN CANCER-CHEMOTHERAPY - MACROMOLECULAR PRODRUGS | 1995 | 87 | 150 | 19% |
Methotrexate: a detailed review on drug delivery and clinical aspects | 2012 | 14 | 107 | 14% |
MOLECULAR DESIGN OF METHOTREXATE-ANTIBODY CONJUGATES FOR TARGETED CANCER-TREATMENT | 1992 | 3 | 44 | 64% |
CHEMICAL MODIFICATION OF ANTIBODIES FOR CANCER-CHEMOTHERAPY | 1988 | 20 | 84 | 33% |
CHEMOIMMUNOCONJUGATES FOR THE TREATMENT OF CANCER | 1994 | 26 | 260 | 12% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP PEPTIDE CHEM | 6 | 15% | 8.8% | 38 |
2 | HUNGARIAN SCI PEPTIDE CHEM GRP | 4 | 67% | 0.9% | 4 |
3 | EXPT ANTICANC THER Y | 2 | 50% | 0.7% | 3 |
4 | RADIOCHEM RADIOPHARMACOL E0300 | 1 | 100% | 0.5% | 2 |
5 | TB RELATED INFECT UNITMRCCLIN SCI | 1 | 100% | 0.5% | 2 |
6 | CLIN INTERNAL MED 5 | 1 | 25% | 0.7% | 3 |
7 | ABORAT MOL BIOL NOVEL THER EUT STRATEG | 1 | 50% | 0.2% | 1 |
8 | CANC TRANSPLANTAT | 1 | 50% | 0.2% | 1 |
9 | IMPERAL | 1 | 50% | 0.2% | 1 |
10 | INTERNAL MED CLIN PHARMACOL PHARMAEPIDEMIO | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000181081 | HPMA COPOLYMERS//HPMA COPOLYMER//POLYMER THER EUT |
2 | 0.0000159920 | ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1 |
3 | 0.0000126830 | DRUG DELIVERY//GALACTOSYLATED LIPOSOMES//N SUCCINYL CHITOSAN |
4 | 0.0000117984 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY |
5 | 0.0000094203 | PEPTIDE PROT CHEM//PHYSICOCHEM UNIT//QUIM PEPTIDS PROT |
6 | 0.0000080183 | GIRENTUXIMAB//G250//MONOCLONAL ANTIBODY CG250 |
7 | 0.0000079916 | CASEIN NANOPARTICLES//ALBUMIN MICROSPHERE//ALBUMIN MICROSPHERES |
8 | 0.0000076830 | CHAIN COPOLYMERIZATION//INHIBITORS OF AGGREGATION//INVIVO CULTURE |
9 | 0.0000068121 | CB1954//ADEPT//ANTIBODY DIRECTED ENZYME PRODRUG THERAPY |
10 | 0.0000066822 | BOVINE SERUM ALBUMIN NANOPARTICLES//HUMAN SERUM ALBUMIN NANOPARTICLES//COACERVATION METHOD |